BPG is committed to discovery and dissemination of knowledge
Observational Study
©The Author(s) 2017.
World J Gastrointest Pharmacol Ther. May 6, 2017; 8(2): 137-146
Published online May 6, 2017. doi: 10.4292/wjgpt.v8.i2.137
Table 3 Safety profile n (%)
Patientsn = 462
Severe AEs
Any AE111 (2.4)
AEs321 (69.5)
Fatigue104 (22.5)
Headache55 (11.7)
Anemia52 (11.3)
Insomnia23 (5.0)
Infection20 (4.3)
Arthralgia, myalgia19 (4.1)
Dyspepsia15 (3.2)
Rash14 (3.0)
Deaths0 (0.0)

  • Citation: Ramos H, Linares P, Badia E, Martín I, Gómez J, Almohalla C, Jorquera F, Calvo S, García I, Conde P, Álvarez B, Karpman G, Lorenzo S, Gozalo V, Vásquez M, Joao D, de Benito M, Ruiz L, Jiménez F, Sáez-Royuela F, Asociación Castellano y Leonesa de Hepatología (ACyLHE). Interferon-free treatments in patients with hepatitis C genotype 1-4 infections in a real-world setting. World J Gastrointest Pharmacol Ther 2017; 8(2): 137-146
  • URL: https://www.wjgnet.com/2150-5349/full/v8/i2/137.htm
  • DOI: https://dx.doi.org/10.4292/wjgpt.v8.i2.137

Write to the Help Desk